Skip to Content

Eptifibatide Injection

Last Updated: August 11, 2016
Status: Resolved

Eptifibatide Injection

Reason for the Shortage
    • Merck states the reason for the shortage was manufacturing delay.
    • AuroMedics launched eptifibatide injection in December 2015.
Available Products
    • Integrilin injection, Merck, 0.75 mg/mL, 100 mL vial, 1 count, NDC 00085-1136-01
    • Integrilin injection, Merck, 2 mg/mL, 10 mL vial, 1 count, NDC 00085-1177-01
    • Integrilin injection, Merck, 2 mg/mL, 100 mL vial, 1 count, NDC 00085-1177-02
    • Eptifibatide injection, AuroMedics, 0.75 mg/mL, 100 mL vial, 1 count, NDC 55150-0218-99
    • Eptifibatide injection, AuroMedics, 2 mg/mL, 10 mL vial, 1 count, NDC 55150-0219-10
    • Eptifibatide injection, AuroMedics, 2 mg/mL, 100 mL vial, 1 count, NDC 55150-0220-99

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated August 11, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 23, 2015 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide